A systematic review and meta-analysis of the prevalence of dyslipidaemia among adults in Malaysia

• Published in: Scientific reports Vol. 13; no. 1; p. 11036
• Main Authors: Mohamed-Yassin, Mohamed-Syarif, Rosman, Norhidayah, Kamaruddin, Khairatul Nainey, Miptah, Hayatul Najaa, Baharudin, Noorhida, Ramli, Anis Safura, Abdul-Razak, Suraya, Lai, Nai Ming
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.07.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308/174; 692/699/2743/2099; 692/699/75/2099; Cardiovascular diseases; Cholesterol; Dyslipidemia; Health risks; High density lipoprotein; Humanities and Social Sciences; Low density lipoprotein; Meta-analysis; Metabolic disorders; multidisciplinary; Observational studies; Reviews; Risk factors; Science; Science (multidisciplinary); Systematic review; Triglycerides; Malaysia
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-38275-7

Dyslipidaemia is an established cardiovascular risk factor. This study aimed to determine the pooled prevalence of dyslipidaemia in Malaysian adults. A systematic review and meta-analysis of all cross-sectional, longitudinal observational studies which reported the prevalence of elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), triglycerides (TG), and reduced high-density lipoprotein cholesterol (HDL-c) in adults 18 years old and older, was conducted. A comprehensive search of PubMed and Cochrane Central Register of Controlled Trials (which included Medline, EMBASE and major trial registers) from inception to October 18, 2022, was performed. Risk-of-bias was evaluated using the Johanna-Briggs Institute Prevalence Critical Appraisal Tool, while certainty of evidence was assessed using an adapted version of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Random-effects meta-analyses were performed using MetaXL. This report follows the PRISMA reporting guidelines. The protocol was registered with PROSPERO (CRD42020200281). 26 556 studies were retrieved and 7 941 were shortlisted initially. From this, 70 Malaysian studies plus two studies from citation searching were shortlisted; 46 were excluded, and 26 were included in the review (n = 50 001). The pooled prevalence of elevated TC (≥ 5.2 mmol/L), elevated LDL-c (≥ 2.6 mmol/L), elevated TG (≥ 1.7 mmol/L), and low HDL-c (< 1.0 mmol/L in men and < 1.3 mmol/L in women) were 53% (95% CI 39–67%, I 2  = 100%), 73% (95% CI 50–92%, I 2  = 100%), 36% (95% CI 32–40%, I 2  = 96%), and 40% (95% CI 25–55%, I 2  = 99%), respectively. This review found that the prevalence of all dyslipidaemia subtypes is high in Malaysian adults. Ongoing efforts to reduce cardiovascular diseases in Malaysia should integrate effective detection and treatment of dyslipidaemia.